Related Experiment Videos
Early pregnancy failure--current management concepts.
M D Creinin1, J L Schwartz, R S Guido
1Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Women's Hospital, Pennsylvania 15213-3180, USA.
Obstetrical & Gynecological Survey
|February 24, 2001
Summary
Early pregnancy failure management options are evolving beyond traditional D&C. Expectant management may pose risks, while medical management with misoprostol shows promise but requires more research.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
Background:
- Miscarriage affects approximately 25% of women.
- Dilatation and curettage (D&C) has been the standard for over 50 years.
- D&C is typically performed in an operating room, increasing costs.
Purpose of the Study:
- To review current management options for early pregnancy failure.
- To evaluate the efficacy and safety of expectant management, outpatient D&C, and medical management with misoprostol.
- To highlight the need for more large-scale studies on treatment efficacy and patient preferences.
Main Methods:
- Literature review of studies on early pregnancy failure management.
- Analysis of data regarding expectant management, D&C (including manual vacuum aspiration), and misoprostol treatment.
- Assessment of complication rates, efficacy, and patient acceptability.
Main Results:
- Expectant management may lead to complications if not properly managed.
- Outpatient D&C using manual vacuum aspiration is a safe alternative.
- Vaginal misoprostol demonstrates high expulsion rates (80-90%) up to 13 weeks gestation, but data is limited.
Conclusions:
- There is a lack of comprehensive data on the relative efficacy, side effects, and acceptability of different management options.
- Further large-scale studies are needed to guide clinical decision-making for early pregnancy failure.
- Women generally prefer active management strategies.